Photodynamic therapy for neovascular age-related macular degeneration
about
Anti-vascular endothelial growth factor for neovascular age-related macular degenerationSurgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degenerationAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degenerationSurgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degenerationLaser photocoagulation for neovascular age-related macular degenerationCost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration.Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers.Transcriptional factors associated with epithelial-mesenchymal transition in choroidal neovascularization.Cochrane systematic reviews and co-publication: dissemination of evidence on interventions for ophthalmic conditions.Routine eye examinations for persons 20-64 years of age: an evidence-based analysis.Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular DegenerationObesity and eye diseases.Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis).Treatment of age-related macular degeneration: focus on ranibizumabThe treatment of wet age-related macular degeneration.Photodynamic Inactivation of Herpes Simplex Viruses
P2860
Q24194251-B7689242-7267-46CC-AE51-1301805F89AEQ24201624-C00D03C0-7FFC-4192-981D-ACA9F7B0B97BQ24243234-9E4DEA97-4DDB-46EE-BF3B-8997CC5F24B2Q24243503-2A0FD8C8-5D11-4B4D-AC17-6F30CE81970EQ24244141-E8FBE816-FFC2-4176-A3ED-6AE057B6A418Q33944980-1C1A19A9-3778-4B00-8559-6C3326EF98A0Q34108491-97015C76-52D2-4F64-A0BC-30042A89AA7FQ35007241-595C889C-0E6D-4CBB-9532-5E4A09CF1B5FQ35784004-5AE3B7EE-0EBD-4248-BDA7-B39A4FA6C8ACQ36046982-AE3FC3E3-6D65-4C11-91BF-7E69B4F99202Q36088747-89013C67-97A2-47C9-ADE6-379340151C4FQ36758799-1EA6370C-8266-4F9D-BA62-7FCEBBB2F5F3Q37232522-5BE33977-19E5-45A2-9D4F-B2C8E5A99EF1Q37233230-E1FB688B-301B-45BF-9F7F-B3C8522C10E8Q37527988-A85E67CD-8A45-4C8E-97DC-067DC7176773Q57065815-64F99890-08C9-4300-8BA0-C94C0138D230
P2860
Photodynamic therapy for neovascular age-related macular degeneration
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Photodynamic therapy for neovascular age-related macular degeneration
@ast
Photodynamic therapy for neovascular age-related macular degeneration
@en
Photodynamic therapy for neovascular age-related macular degeneration
@en-gb
Photodynamic therapy for neovascular age-related macular degeneration
@nl
type
label
Photodynamic therapy for neovascular age-related macular degeneration
@ast
Photodynamic therapy for neovascular age-related macular degeneration
@en
Photodynamic therapy for neovascular age-related macular degeneration
@en-gb
Photodynamic therapy for neovascular age-related macular degeneration
@nl
prefLabel
Photodynamic therapy for neovascular age-related macular degeneration
@ast
Photodynamic therapy for neovascular age-related macular degeneration
@en
Photodynamic therapy for neovascular age-related macular degeneration
@en-gb
Photodynamic therapy for neovascular age-related macular degeneration
@nl
P2093
P2860
P1476
Photodynamic therapy for neovascular age-related macular degeneration
@en
P2093
P2860
P356
10.1002/14651858.CD002030.PUB2
P577
2005-10-19T00:00:00Z